It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Cardinal Health (CAH) has drawn investor attention after its stock closed at $221.77. This has put recent performance and current valuation metrics in focus for those tracking large U.S. healthcare ...

Cardinal Health continues to face aggressive competition from McKesson and Cencora, both of which are pursuing similar specialty-driven strategies. McKesson delivered 18% adjusted EPS growth in fiscal ...

Cardinal Health (CAH) closed at $237.92 in the latest trading session, marking a +1.35% move from the prior day.

Cardinal Health's CAH pharmaceutical segment has consistently demonstrated resilience and growth, driven by strong demand across brand, specialty, and generic pharmaceuticals. Historical performance ...

Cardinal Health remains in focus as steady healthcare distribution demand and higher-value expansion support its market relevance.

Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock ...

Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and strong quarterly earnings. However, the possibility of losing a major ...